Related Experiment Video

Updated: Mar 17, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.4K

Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients

Wen-Ya Zhou1, Hong Zheng2, Xiao-Ling Du3

  • 1Department of Bone and Soft Tissue Tumor.

Cancer Biology & Medicine
|July 27, 2016
PubMed

Insights

Fibroblast growth factor receptor (FGFR) signaling is crucial for cell functions but often deregulated in cancers. This review explores the FGF/FGFR pathway

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The fibroblast growth factor receptor (FGFR) family regulates critical cellular processes.
  • Aberrant FGF/FGFR signaling is implicated in various cancers and developmental disorders.
  • Sarcomas exhibit poor outcomes with conventional therapies, highlighting the need for novel treatment strategies.

Purpose of the Study:

  • To review the role of the FGF/FGFR signaling pathway in sarcoma development and progression.
  • To discuss the potential of FGFR inhibitors as targeted therapies for sarcoma treatment.

Main Methods:

  • Literature review of recent research on the FGF/FGFR pathway in sarcoma.
  • Analysis of studies investigating FGFR inhibitors in cancer therapy.

Main Results:

  • The FGF/FGFR pathway plays a significant role in sarcoma biology.
  • FGFR inhibitors show promise as targeted therapeutic agents for sarcomas.

Conclusions:

  • Targeting the FGF/FGFR pathway represents a potential new avenue for sarcoma treatment.
  • Further research into FGFR inhibitors is warranted for clinical application in sarcoma.
Keywords:
FGFR inhibitorsFGFR signaling pathwaySarcoma

More Related Videos

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

8.3K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.8K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K